| Serial Number | 97368267 |
| Word Mark | EVOPEPDYS |
| Filing Date | Monday, April 18, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, October 27, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 21, 2023 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, October 31, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 27, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, October 27, 2023 | SOU EXTENSION 1 FILED |
| Friday, October 27, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, February 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 3, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 21, 2022 | NEW APPLICATION ENTERED |